AKBA
NASDAQStockAkebia Therapeutics, Inc.
$1.40+0.00 (+0.00%)
52-Week Range
$1.18
$4.01
Key Stats
Market Cap
375.0M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.40
Volume
2.2M
Avg Volume
3.2M
Performance
1M
-9.68%
3M
-13.04%
6M
-52.05%
YTD
-9.68%
1Y
-17.16%
3Y
+104.92%
5Y
-61.11%
Price Chart
ETF Exposure
AKBA is held by 51 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.42% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.26% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.23% |
| XBI | State Street SPDR S&P Biotech ETF | 0.14% |
| VFMF | Vanguard U.S. Multifactor ETF | 0.07% |
| IWC | iShares Micro-Cap ETF | 0.07% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.06% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.04% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.04% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.03% |
| PWS | Pacer WealthShield ETF | 0.03% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.02% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.02% |
| IWN | iShares Russell 2000 Value ETF | 0.02% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.02% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
Page 1 of 2Next
About AKBA ETF Exposure
Akebia Therapeutics, Inc. (AKBA) is held by 51 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 375.0M, AKBA is a widely held institutional stock. The stock currently trades at $1.40. Investors can gain exposure to AKBA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AKBA, sorted by portfolio weight.